In relation to the risk of developing cancer, a study published in The Journal of Clinical Endocrinology & Metabolism found no significant association between the dose of rhGH, mortality, and cancer incidence, making causality far less likely: Safety concerns have been raised regarding premature mortality, diabetes, neoplasia, and cerebrovascular disease in association with GH therapy
Knekt P, Reunanen A, Jarvinen R, Seppanen R, Heliovaara M, Aromaa A: Antioxidant vitamin intake and coronary mortality in a longitudinal population study
It can vary based on things like inflation, manufacturer policies, and even the pharmacy location
The incretin effect in T2DM Hormonal regulation of glucose metabolism extends well beyond the physiologic effects of insulin and glucagon
It is often included in routines focused on physical performance, mental clarity, and overall energy metabolism